ERBB2 and breast carcinoma: The study cohort comprised 13,824 HER2-negative breast cancer patients from seven HCOs within GRN (n = 298 patients were excluded from the study cohort during manual evaluation because they had conflicting results which the NLP algorithm could not resolve).